These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10547427)

  • 41. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination.
    Thomson SA; Sherritt MA; Medveczky J; Elliott SL; Moss DJ; Fernando GJ; Brown LE; Suhrbier A
    J Immunol; 1998 Feb; 160(4):1717-23. PubMed ID: 9469429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential cellular and humoral immune responses to HCV core and HBV envelope proteins after genetic immunizations using chimeric constructs.
    Geissler M; Tokushige K; Wakita T; Zurawski VR; Wands JR
    Vaccine; 1998 May; 16(8):857-67. PubMed ID: 9627944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal induction of T-cell responses against hepatitis C virus E2 by antigen engineering in DNA immunization.
    Youn JW; Park SH; Cho JH; Sung YC
    J Virol; 2003 Nov; 77(21):11596-602. PubMed ID: 14557645
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparison of immune responses induced by recombinant attenuated Salmonella typhi carrying eukaryotic expression plasmid or prokaryotic expression plasmid of HCV core protein].
    Chen ZH; Zhao P; Wu SM; Cao J; Zhang B; Wan MB; Ke JS; Qi ZT
    Sheng Wu Gong Cheng Xue Bao; 2007 Sep; 23(5):862-6. PubMed ID: 18051866
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immune responses to recombinant expression plasmid encoding hepatitis C virus core antigen].
    Feng Z; Zhou Y; Jia Z; Lian J; Li J; Li W
    Zhonghua Nei Ke Za Zhi; 1999 Jul; 38(7):462-5. PubMed ID: 11798682
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancement of immunoglobulin G2a and cytotoxic T-lymphocyte responses by a booster immunization with recombinant hepatitis C virus E2 protein in E2 DNA-primed mice.
    Song MK; Lee SW; Suh YS; Lee KJ; Sung YC
    J Virol; 2000 Mar; 74(6):2920-5. PubMed ID: 10684312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain.
    Mikkelsen M; Holst PJ; Bukh J; Thomsen AR; Christensen JP
    J Immunol; 2011 Feb; 186(4):2355-64. PubMed ID: 21257961
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenicity of the E1E2 proteins of hepatitis C virus expressed by recombinant adenoviruses.
    Seong YR; Choi S; Lim JS; Lee CH; Lee CK; Im DS
    Vaccine; 2001 Apr; 19(20-22):2955-64. PubMed ID: 11282207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhancement of immune response to a hepatitis C virus E2 DNA vaccine by an immunoglobulin Fc fusion tag.
    Sun W; Li Q; Zhu D; Feng J; Zhuang Z; Sun X; Xiao G; Duan Y
    J Med Virol; 2015 Dec; 87(12):2090-7. PubMed ID: 26010499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro studies of core peptide-bearing immunopotentiating reconstituted influenza virosomes as a non-live prototype vaccine against hepatitis C virus.
    Hunziker IP; Grabscheid B; Zurbriggen R; Glück R; Pichler WJ; Cerny A
    Int Immunol; 2002 Jun; 14(6):615-26. PubMed ID: 12039913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immune responses against hepatitis C virus structural proteins following genetic immunisation.
    Inchauspé G; Major ME; Nakano I; Vivitski L; Maisonnas M; Trépo C
    Dev Biol Stand; 1998; 92():163-8. PubMed ID: 9554271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficient induction of mouse immune responses to hepatitis C virus by viral core protein-carrying attenuated Salmonella typhimurium.
    Liao XL; Ren H; Zhao P; Zhu SY; Cao J; Chen ZH; Zhao LJ; Pan W; Feitelson MA; Qui ZT
    Viral Immunol; 2007 Sep; 20(3):469-78. PubMed ID: 17931117
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunization with recombinant Calmette-Guerin bacillus (BCG)-hepatitis C virus (HCV) elicits HCV-specific cytotoxic T lymphocytes in mice.
    Uno-Furuta S; Matsuo K; Tamaki S; Takamura S; Kamei A; Kuromatsu I; Kaito M; Matsuura Y; Miyamura T; Adachi Y; Yasutomi Y
    Vaccine; 2003 Jul; 21(23):3149-56. PubMed ID: 12804842
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Engineering of N-glycosylation of hepatitis C virus envelope protein E2 enhances T cell responses for DNA immunization.
    Li P; Wan Q; Feng Y; Liu M; Wu J; Chen X; Zhang XL
    Vaccine; 2007 Feb; 25(8):1544-51. PubMed ID: 17055129
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systematic analysis of attenuated Coxsackievirus expressing a foreign gene as a viral vaccine vector.
    Kim DS; Cho YJ; Kim BG; Lee SH; Nam JH
    Vaccine; 2010 Feb; 28(5):1234-40. PubMed ID: 19941986
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Study of neutralization antibodie induced by DNA vaccine of HCV envelope protein 2 in mice].
    Shao S; Zhou H; Tong Y; Ren Y; Chen Z
    Wei Sheng Yan Jiu; 2011 May; 40(3):295-8. PubMed ID: 21695897
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preclinical evaluation of multi antigenic HCV DNA vaccine for the prevention of Hepatitis C virus infection.
    Lee H; Jeong M; Oh J; Cho Y; Shen X; Stone J; Yan J; Rothkopf Z; Khan AS; Cho BM; Park YK; Weiner DB; Son WC; Maslow JN
    Sci Rep; 2017 Mar; 7():43531. PubMed ID: 28266565
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunization with a Recombinant Expression Vector Encoding NS3/NS4A of Hepatitis C Virus Genotype 3a Elicits Cell-Mediated Immune Responses in C57BL/6 Mice.
    Behzadi MA; Alborzi A; Kalani M; Pouladfar G; Dianatpour M; Ziyaeyan M
    Viral Immunol; 2016 Apr; 29(3):138-47. PubMed ID: 26909520
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunogenicity evaluation of a DNA vaccine expressing the hepatitis C virus non-structural protein 2 gene in C57BL/6 mice.
    Gorzin Z; Gorzin AA; Tabarraei A; Behnampour N; Irani S; Ghaemi A
    Iran Biomed J; 2014; 18(1):1-7. PubMed ID: 24375156
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of hepatitis C virus vaccine using hepatitis B core antigen as immuno-carrier.
    Chen JY; Li F
    World J Gastroenterol; 2006 Dec; 12(48):7774-8. PubMed ID: 17203519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.